Sumitomo Dainippon Pharma Co., Ltd. reported consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales of JPY 100.8 billion compared to JPY 103.1 billion a year ago. Operating income was JPY 10.9 billion compared to JPY 17.2 billion a year ago. Ordinary income was JPY 9.8 billion compared to JPY 16.9 billion a year ago. Net income was JPY 7.2 billion compared to JPY 10.5 billion a year ago. Income before income taxes and minority interests was JPY 12.2 billion compared to JPY 16.8 billion a year ago.

For the nine months, the company reported net sales of JPY 279.1 billion compared to JPY 284.5 billion a year ago. Operating income was JPY 22.8 billion compared to JPY 34.7 billion a year ago. Ordinary income was JPY 22.5 billion compared to JPY 34.3 billion a year ago. Net income was JPY 19.0 billion compared to JPY 19.2 billion a year ago. EBITDA was JPY 37.3 billion compared to JPY 55.2 billion a year ago. Net cash provided by operating activities was JPY 26.9 billion compared to JPY 35.4 billion a year ago. Return on equity was 4.5% compared to 5.1% a year ago. Earnings per share were JPY 47.81 compared to JPY 48.22 a year ago. Capital expenditures were JPY 8.5 billion compared to JPY 11.3 billion a year ago. Income before income taxes and minority interests was JPY 34.3 billion compared to JPY 31.8 billion a year ago.

The company revised earnings guidance for the fiscal year 2014. For the year, the company expects net sales of JPY 371.0 billion, operating income of JPY 20.0 billion, ordinary income of JPY 20.0 billion, net income of JPY 12.5 billion and EBITDA of JPY 39.5 billion compared to previous guidance of net sales of JPY 366.0 billion, operating income of JPY 20.0 billion, ordinary income of JPY 19.5 billion, net income of JPY 14.0 billion and EBITDA of JPY 39.0 billion. The company expects capital expenditures of JPY 12.0 billion and depreciation and amortization on property, plant and equipment of JPY 7.3 billion, on intangible assets of JPY 4.2 billion and on goodwill of JPY 5.5 billion. The company expects earnings per share of JPY 31.46 compared to previous guidance earnings per share of JPY 35.24.

The company forecasts year dividend of JPY 9.00 per share compared to JPY 9.00 a year ago.